SC 13G 1 tm226458d4_sc13g.htm SC 13G

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. )*

Enfusion, Inc.
(Name of Issuer)

Class A common stock, par value $0.001 per share
(Title of Class of Securities)

292812104
(CUSIP Number)

December 31, 2021
(Date of Event Which Requires Filing of this Statement)

Check the Appropriate Box to Designate the Rule Pursuant to Which this Schedule Is Filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

1.	Names of Reporting Persons FTV IV, L.P.
2.	Check The Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned By Each Reporting Person With	5.	Sole Voting Power 0
	6.	Shared Voting Power 31,297,606
	7.	Sole Dispositive Power 0
	8.	Shared Dispositive Power 31,297,606

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 31,297,606
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares ¨
11.	Percent of Class Represented By Amount in Row (9) 47.72%⁽¹⁾
12.	Type of Reporting Person (See Instructions) PN

(1) Calculated based on 65,583,288 shares of Class A common stock outstanding as of December 3, 2021 as reported on the Issuer’s Form 10-Q, filed on December 3, 2021.

1.	Names of Reporting Persons FTV Management IV, L.L.C.
2.	Check The Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned By Each Reporting Person With	5.	Sole Voting Power 0
	6.	Shared Voting Power 31,297,606
	7.	Sole Dispositive Power 0
	8.	Shared Dispositive Power 31,297,606

9.	Aggregate Amount Beneficially Owned by Each Reporting Person 31,297,606
10.	Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares ¨
11.	Percent of Class Represented By Amount in Row (9) 47.72%⁽¹⁾
12.	Type of Reporting Person (See Instructions) OO

(1) Calculated based on 65,583,288 shares of Class A common stock outstanding as of December 3, 2021 as reported on the Issuer’s Form 10-Q, filed on December 3, 2021.

Item 1(a).	Name of Issuer
	Enfusion, Inc. (the “Issuer”)
Item 1(b).	Address of the Issuer’s Principal Executive Offices
	125 South Clark Street, Suite 750 Chicago, IL 60603
Item 2(a).	Names of Persons Filing
	This statement is filed by the entities and persons listed below, all of whom together are referred to herein as the “Reporting Persons”: (i) FTV IV, L.P. (ii) FTV Management IV, L.L.C.
Item 2(b).	Address of the Principal Business Office, or if none, Residence:
	601 California Street, Floor 19 San Francisco, CA 94108
Item 2(c).	Citizenship
	See responses to Item 4 on each cover page.
Item 2(d).	Title of Class of Securities
	Class A common stock, par value $0.001 per share.
Item 2(e).	CUSIP Number
	292812104
Item 3.	If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a(n):
	Not Applicable.

Item 4.

Ownership

	(a)	Amount beneficially owned:
		See responses to Item 9 on each cover page.
	(b)	Percent of Class:
		See responses to Item 11 on each cover page.
	(c)	Number of shares as to which the Reporting Person has:

		(i)	Sole power to vote or to direct the vote:
			See responses to Item 5 on each cover page.
		(ii)	Shared power to vote or to direct the vote:
			See responses to Item 6 on each cover page.
		(iii)	Sole power to dispose or to direct the disposition of:
			See responses to Item 7 on each cover page.
		(iv)	Shared power to dispose or to direct the disposition of:
			See responses to Item 8 on each cover page.

The reported securities are directly held by FTV IV, L.P. (“FTV”). FTV Management IV, L.L.C. is the general partner of FTV and exercises voting and dispositive power with regard to the shares directly held by FTV IV, L.P. The filing of this Statement shall not be construed as an admission that either Reporting Person is the beneficial owner of any securities covered by this Statement.

Item 5.	Ownership of Five Percent or Less of a Class
	Not Applicable.
Item 6.	Ownership of More than Five Percent on Behalf of Another Person
	Not Applicable.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
	Not Applicable.
Item 8.	Identification and Classification of Members of the Group
	Not Applicable.
Item 9.	Notice of Dissolution of Group
	Not Applicable.
Item 10.	Certification
	Not Applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2022

	FTV IV, L.P.


	/s/ Blake Nielsen
	Name:	Blake Nielsen
	Title:	Attorney-in-Fact

	FTV Management IV, L.L.C.


	/s/ Bradford E. Bernstein
	Name:	Bradford E Bernstein
	Title:	Managing Member

EXHIBIT LIST

Exhibit A

Joint Filing Agreement, dated as of February 14, 2022

SEC Form SC 13G filed by Enfusion Inc.